Skip to main content
Premium Trial:

Request an Annual Quote

Hygiena Completes Acquisition of DuPont Global Food Safety Dx Business

NEW YORK (GenomeWeb) – Microbiology and life science company Hygiena said today that it has completed its previously announced acquisition of DuPont's global food safety diagnostics business.

The business — originally known as Qualicon — includes all of DuPont Diagnostics' assets, including the BAX foodborne pathogens and spoilage organisms testing platform; the RiboPrinter contaminating organism differentiation and identification system; BAX- and RiboPrinter-associated test kits; a sales, R&D, and manufacturing organization; and in-house production capacity. Hygiena said that it will sell DuPont Diagnostics products through its Qualicon Diagnostics unit.

Financial terms of the deal, which was announced in December, were not disclosed.

"We are excited to welcome the DuPont Diagnostics team to Hygiena and look forward to better serving our global food and beverage customers by offering a wider food safety testing portfolio," Hygiena CEO Steven Nason said in a statement. "Hygiena now offers testing solutions to cover the full food manufacturing process, from sanitation monitoring to finished product testing."

The Scan

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Targets Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.